Effects of Perioperative Administration of Dexamethasone on Postoperative Complications and Mortality After Non-cardiac Major Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

1,222

Participants

Timeline

Start Date

December 13, 2017

Primary Completion Date

April 16, 2019

Study Completion Date

April 16, 2019

Conditions
Major Non-cardiac Surgery
Interventions
DRUG

Dexamethasone

Dexamethasone : first dose : 0,2mg.kg-1 at the end of the surgical procedure, second dose (0,2 mg.kg-1) 24 hours after the surgery

DRUG

Placebos

placebo : first infusion at the end of the surgical procedure, second 24 hours after the surgery

Trial Locations (29)

13009

Institut Paoli Calmettes, Marseille

13385

Hôpital Timone, Marseille

13975

Hôpital Nord, Marseille

29107

Ch Quimper, Quimper

29609

CHU La Cavale Blanche, Brest

31059

CHU de Toulouse, Toulouse

34295

Hôpital Saint-Eloi, Montpellier

35033

Hôpital Pontchaillou, Rennes

42055

CHU Saint Etienne, Saint-Etienne

44000

Clinique Jules Verne, Nantes

Le Confluent, Nantes

44093

Hotel Dieu Nantes, Nantes

Hôpital Laennec, Nantes

44805

C.R.L.C.C. Nantes Atlantique, Nantes

49933

CHU Angers, Angers

59037

Hôpital Claude Huriez, Lille

59300

CH Valenciennes, Valenciennes

63000

Hôpital Estaing, CHU de Clermont Ferrand, Clermont-Ferrand

67098

Nouvel Hôpital Civil, Strasbourg

69003

Hopital Edouard Herriot, Lyon

69310

CHU Lyon Sud, Pierre-Bénite

72037

Centre Hospitalier Du Mans, Le Mans

75000

Hôpital Saint Antoine, Paris

75475

Hôpitaux Universitaires Saint-Louis, Lariboisière, Fernand Widal, Paris

76031

CHU de Rouen, Rouen

85000

CHD Vendée, La Roche-sur-Yon

86021

CHU de Poitiers, Poitiers

92110

Hôpital Beaujon, Clichy

94805

Institut Gustave Roussy, Villejuif

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT03218553 - Effects of Perioperative Administration of Dexamethasone on Postoperative Complications and Mortality After Non-cardiac Major Surgery | Biotech Hunter | Biotech Hunter